Ulcerative Colitis Patients News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ulcerative colitis patients. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ulcerative Colitis Patients Today - Breaking & Trending Today

Cureus | Quality of Life in Patients With Inflammatory Bowel Disease: Importance of Psychological Symptoms

Background

Depressive, anxiety, and stress symptoms are prevalent in patients with inflammatory bowel disease (IBD) and may negatively influence the disease course and quality of life. The study aimed to assess the relationship between psychological factors and patients’ quality of life (QoL).

Materials and methods

A cross-sectional study with the use of a structured questionnaire among 38 patients with Crohn’s disease and 30 with ulcerative colitis was conducted. The inflammatory bowel disease questionnaire (IBDQ-32) was used to evaluate the patients’ quality of life, and the Depression, Anxiety, Stress Scale (DASS21) was used to evaluate these psychological factors. Pearson descriptive statistics and multiple regression analyses were performed.

Results

According to the findings of the multiple regression analysis, depressive, anxiety, and stress symptoms were negatively associated with quality of life. Participants with higher score ....

New York , United States , Eteläuomen Läi , Hellenic Society Of Crohn Disease , World Health Organization , Stress Scale , Ulcerative Colitis Patients , Ulcerative Colitis , Inflammatory Bowel Disease Questionnaire , South Western Greece ,

Eli Lilly and : Mirikizumab Improves Fatigue in Patients with Crohn's Disease in Phase 2 Trial

INDIANAPOLIS, May 22, 2021 /PRNewswire/ In a pre-specified analysis of the Phase 2 SERENITY study, Eli Lilly and Company s mirikizumab improved fatigue in patients with moderately to severely. | May 22, 2021 ....

United States , Miguel Regueiro , Kevin Hern , Eli Lilly , Exchange Commission , Eli Lilly Company , Prospective Adult Research Cohort , Digestive Disease , Cleveland Clinic , Demonstrated Improvements , Fatigue Among Patients , Higher Levels , Disease Activity , Decreased Work Productivity , Reduced Well Being , Inflammatory Bowel Disease , About The , Improved Fatigue , Severely Active Crohn , Simple Endoscopic Score , Ulcerative Colitis Patients , Activity Index , Mirikizumab Phase , Private Securities Litigation Reform Act , United States Securities , Jen Dial ,

Mirikizumab Improves Fatigue in Patients with Crohn's Disease in Phase 2 Trial

Mirikizumab Improves Fatigue in Patients with Crohn's Disease in Phase 2 Trial
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Miguel Regueiro , Kevin Hern , Eli Lilly , Exchange Commission , Eli Lilly Company , Prospective Adult Research Cohort , Digestive Disease , Cleveland Clinic , Demonstrated Improvements , Fatigue Among Patients , Higher Levels , Disease Activity , Decreased Work Productivity , Reduced Well Being , Inflammatory Bowel Disease , About The , Improved Fatigue , Severely Active Crohn , Simple Endoscopic Score , Ulcerative Colitis Patients , Activity Index , Mirikizumab Phase , Private Securities Litigation Reform Act , United States Securities , Jen Dial ,